Page 2 - Edwardp Feener News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Edwardp feener. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Edwardp Feener Today - Breaking & Trending Today

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) to Post Q3 2024 Earnings of ($0.69) Per Share, Leerink Partnrs Forecasts

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Free Report) – Leerink Partnrs lowered their Q3 2024 earnings per share (EPS) estimates for KalVista Pharmaceuticals in a research report issued on Tuesday, February 13th. Leerink Partnrs analyst J. Schwartz now expects that the specialty pharmaceutical company will post earnings per share of ($0.69) for the quarter, down from […] ....

United States , Hong Kong , Leerink Partnrs , Edwardp Feener , China Universal Asset Management Co , Hong Kong Ltd , Tower Research Capital , Securities Exchange Commission , Kalvista Pharmaceuticals Stock Performance , News Ratings For Kalvista Pharmaceuticals Daily , Kalvista Pharmaceuticals Inc , Needham Company , Kalvista Pharmaceuticals Company Profile , Kalvista Pharmaceuticals , Institutional Trading Of Kalvista Pharmaceuticals , Royal Bank , Free Report , Kalvista Pharmaceutical , Vista Pharmaceuticals , Get Free Report , Venrock Healthcare Capital Par , Exchange Commission , Kong Ltd , Research Capital , Universal Asset Management , Kalvista Pharmaceuticals Daily ,

KalVista Pharmaceuticals (NASDAQ:KALV) Reaches New 52-Week High on Analyst Upgrade

KalVista Pharmaceuticals (NASDAQ:KALV) Reaches New 52-Week High on Analyst Upgrade
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Edwardp Feener , Hedge Funds Weigh In On Kalvista Pharmaceuticals , Kalvista Pharmaceuticals Stock , Kalvista Pharmaceuticals Inc , Kalvista Pharmaceuticals , Securities Exchange Commission , Royal Bank , Needham Company , Tower Research Capital , Insider Transactions At Kalvista Pharmaceuticals , American International Group Inc , News Ratings For Kalvista Pharmaceuticals Daily , Northern Trust Corp , Get Free Report , Vista Pharmaceuticals , Exchange Commission , Venrock Healthcare Capital Par , Trust Corp , International Group , Research Capital , Kalvista Pharmaceuticals Daily ,

KalVista Pharmaceuticals (NASDAQ:KALV) Shares Gap Up on Insider Buying Activity

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) shares gapped up before the market opened on Friday following insider buying activity. The stock had previously closed at $14.90, but opened at $15.47. KalVista Pharmaceuticals shares last traded at $15.38, with a volume of 33,479 shares changing hands. Specifically, major shareholder Venrock Healthcare Capital Par purchased […] ....

Hong Kong , United States , Edwardp Feener , Barclays Plc , China Universal Asset Management Co , Royal Bank , Hong Kong Ltd , Kalvista Pharmaceuticals , Kalvista Pharmaceuticals Inc , Hedge Funds Weigh In On Kalvista Pharmaceuticals , News Ratings For Kalvista Pharmaceuticals Daily , Kalvista Pharmaceuticals Stock , Get Free Report , Vista Pharmaceuticals , Venrock Healthcare Capital Par , Kong Ltd , China Universal Asset Management , Kalvista Pharmaceuticals Daily , Nasdaq Kalv ,

Insider Selling: KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) Insider Sells $224,045.21 in Stock

Insider Selling: KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) Insider Sells $224,045.21 in Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Hong Kong , United States , Edwardp Feener , Hedge Funds Weigh In On Kalvista Pharmaceuticals , Hong Kong Ltd , Barclays Plc , Securities Exchange Commission , Kalvista Pharmaceuticals , News Ratings For Kalvista Pharmaceuticals Daily , Royal Bank , Kalvista Pharmaceuticals Inc , Kalvista Pharmaceuticals Stock Performance , Quarter For Kalvista Pharmaceuticals , Get Free Report , Exchange Commission , Vista Pharmaceuticals , Kong Ltd , Kalvista Pharmaceuticals Daily ,

Insider Selling: KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) Insider Sells 22,679 Shares of Stock

Insider Selling: KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) Insider Sells 22,679 Shares of Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Hong Kong , Edwardp Feener , Barclays Plc , Quarter For Kalvista Pharmaceuticals , Hong Kong Ltd , News Ratings For Kalvista Pharmaceuticals Daily , Kalvista Pharmaceuticals Price Performance , Hedge Funds Weigh In On Kalvista Pharmaceuticals , Royal Bank , Kalvista Pharmaceuticals , Kalvista Pharmaceuticals Inc , Get Free Report , Vista Pharmaceuticals , Kong Ltd , Kalvista Pharmaceuticals Daily ,